Follow
Małgorzata Bajor
Małgorzata Bajor
Mossakowski Medical Research Institute
Verified email at imdik.pan.pl
Title
Cited by
Cited by
Year
Targeting negative and positive immune checkpoints with monoclonal antibodies in therapy of cancer
K Marhelava, Z Pilch, M Bajor, A Graczyk-Jarzynka, R Zagozdzon
Cancers 11 (11), 1756, 2019
1202019
Intrinsic functional potential of NK-cell subsets constrains retargeting driven by chimeric antigen receptors
VYS Oei, M Siernicka, A Graczyk-Jarzynka, HJ Hoel, W Yang, D Palacios, ...
Cancer immunology research 6 (4), 467-480, 2018
872018
Maintenance of long‐term potentiation in hippocampal mossy fiber—CA3 pathway requires fine‐tuned MMP‐9 proteolytic activity
G Wiera, G Wozniak, M Bajor, L Kaczmarek, JW Mozrzymas
Hippocampus 23 (6), 529-543, 2013
672013
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer
PC O’Leary, M Terrile, M Bajor, P Gaj, BT Hennessy, GB Mills, ...
Breast Cancer Research 16, 1-15, 2014
652014
Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma
A Trzeciecka, S Klossowski, M Bajor, R Zagozdzon, P Gaj, A Muchowicz, ...
Oncotarget 7 (2), 1717, 2016
562016
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents
M Bajor, AO Zych, A Graczyk-Jarzynka, A Muchowicz, M Firczuk, ...
British Journal of Cancer 119 (7), 873-884, 2018
542018
Synaptic cell adhesion molecule‐2 and collapsin response mediator protein‐2 are novel members of the matrix metalloproteinase‐9 degradome
M Bajor, P Michaluk, P Gulyassy, AK Kekesi, G Juhasz, L Kaczmarek
Journal of neurochemistry 122 (4), 775-788, 2012
442012
Proteolytic remodeling of the synaptic cell adhesion molecules (CAMs) by metzincins in synaptic plasticity
M Bajor, L Kaczmarek
Neurochemical research 38, 1113-1121, 2013
422013
PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress
M Klopotowska, M Bajor, A Graczyk-Jarzynka, A Kraft, Z Pilch, A Zhylko, ...
Cancer immunology research 10 (2), 228-244, 2022
392022
The immune landscape of breast cancer: strategies for overcoming immunotherapy resistance
K Retecki, M Seweryn, A Graczyk-Jarzynka, M Bajor
Cancers 13 (23), 6012, 2021
362021
Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy.
K Mucha, M Bakun, R Jazwiec, M Dadlez, M Florczak, M Bajor, K Gala, ...
Polish archives of internal medicine 124 (7-8), 380-38, 2014
342014
Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate
A Graczyk-Jarzynka, A Goral, A Muchowicz, R Zagozdzon, M Winiarska, ...
Redox biology 21, 101062, 2019
332019
Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy
M Firczuk, M Bajor, A Graczyk-Jarzynka, K Fidyt, A Goral, R Zagozdzon
Cancer letters 471, 1-11, 2020
302020
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
M Bajor, A Graczyk-Jarzynka, K Marhelava, A Burdzinska, A Muchowicz, ...
Journal for Immunotherapy of Cancer 10 (1), 2022
262022
Triple combination of ascorbate, menadione and the inhibition of peroxiredoxin-1 produces synergistic cytotoxic effects in triple-negative breast cancer cells
M Bajor, A Graczyk-Jarzynka, K Marhelava, M Kurkowiak, A Rahman, ...
Antioxidants 9 (4), 320, 2020
232020
Adenanthin, a new inhibitor of thiol‐dependent antioxidant enzymes, impairs the effector functions of human natural killer cells
M Siernicka, M Winiarska, M Bajor, M Firczuk, A Muchowicz, M Bobrowicz, ...
Immunology 146 (1), 173-183, 2015
222015
Application of genome editing techniques in immunology
AO Zych, M Bajor, R Zagozdzon
Archivum Immunologiae et Therapiae Experimentalis 66, 289-298, 2018
202018
An interplay of S-nitrosylation and metal ion binding for astrocytic S100B protein
M Bajor, M Zaręba-Kozioł, L Zhukova, K Goryca, J Poznański, ...
PLoS One 11 (5), e0154822, 2016
182016
Targeting negative and positive immune checkpoints with monoclonal antibodies in therapy of cancer. Cancers (Basel) 11 (11)
K Marhelava, Z Pilch, M Bajor, A Graczyk-Jarzynka, R Zagozdzon
92019
Inhibition of protein disulfide isomerase induces differentiation of acute myeloid leukemia cells
J Chlebowska-Tuz, O Sokolowska, P Gaj, M Lazniewski, M Firczuk, ...
haematologica 103 (11), 1843, 2018
92018
The system can't perform the operation now. Try again later.
Articles 1–20